NCT07068100Completed
The Effect of Change Stage-Based Physical Activity Counseling on Physically Inactive Individuals With Hypertension
Source: ClinicalTrials.gov · Last updated 16 Jul 2025
Brief summary (registry, in English)
Hypertension (HT) is the second most common disease in Turkey and its prevalence is between 30-35%. Adopting healthy lifestyle behaviors can contribute to the prevention of chronic diseases by preserving well-being. However, it has been determined that the control and protection behaviors of HT patients are inadequate. Guidelines for preventing HT recommend weight loss, healthy nutrition, increased physical activity and reduced alcohol consumption. Obesity and lifestyle changes can reduce blood pressure by 5 mmHg. Practices such as not smoking, physical activity (150 minutes per week), Mediterranean diet and alcohol restriction reduce the risk of HT by 50%. The World Health Organization emphasizes that regular physical activity is important in preventing death and disability. In a study in Turkey involving 15,468 adults, it was determined that only 3.5% of them do regular physical activity. According to the National Household Survey, 20.32% of individuals are sedentary and 15.99% do insufficient physical activity. Despite the abundance of information on the health benefits of physical activity, the question of why adults do not engage in enough physical activity is important. Research is insufficient for physical activity knowledge and behavior change in individuals. Physical activity increase interventions based on theories such as the Transtheoretical Model (TM) are effective for behavior change. TM includes elements such as stages of change, self-efficacy, and decision-making balance. The aim of this study was to investigate the effects of individual physical activity counseling based on the stage of change in physically inactive hypertensive individuals on physical activity levels and the perceived benefits and barriers of individuals' participation in physical activity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 37 (actual)
- First submitted
- 21 Nov 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Ankara City Hospital Bilkent
- Diseases
- High blood pressure
- NCT number
- NCT07068100
What you commit to
- Study type: Interventional
- Participants enrolled: 37
- From 1 Mar 2024 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active infection,
- Having a musculoskeletal or neurological disease that may affect exercise performance, symptomatic heart disease,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- Having any orthopedic or neuromuscular disorder that will prevent walking or exercise performance,
- Having any chronic disease or having psychiatric disorders or mental disorders that may prevent cooperation.
Other
- Being in the maintenance phase according to the change phase diagnosis form.
Who the study is looking for
- Being between the ages of 18-60
- Not doing a minimum of 150 minutes/week of moderate intensity or 75 minutes/week of vigorous intensity physical activity
- Being willing to participate in the study,
- Not having problems reading and/or understanding the scales and being able to cooperate with the tests,
- Having stable and controlled hypertension.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Bilkent City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.